FMI
CRL icon

F/M Investments’s Charles River Laboratories CRL Stock Holding History

F/M Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,570
Closed -$313K – 357
2025
Q4 		$313K Hold
1,570
– – 0.01% 374
2025
Q3 		$246K Sell
1,570
-45
-3% -$7.15K 0.01% 389
2025
Q2 		$245K Buy
1,615
+22
+1% +$2.93K 0.01% 378
2025
Q1 		$240K Sell
1,593
-364
-19% -$61K 0.01% 374
2024
Q4 		$361K Buy
+1,957
New +$377K 0.01% 342
2021
Q4 		– Sell
-6,294
Closed -$2.6M – 86
2021
Q3 		$2.6M Buy
+6,294
New +$2.61M 1.86% 15

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

F/M Investments's CRL Position: Q1 2026 in Review

F/M Investments sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 1,570 shares — an estimated $313K sold.

F/M Investments first reported a position in CRL in Q3 2021 and held it in 6 quarters. The position peaked at $2.6M in Q3 2021. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • F/M Investments reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • F/M Investments sold 1,570 Charles River Laboratories shares in Q1 2026, an estimated $313K.
  • F/M Investments first reported a position in Charles River Laboratories in Q3 2021 and held it in 6 quarters.
  • F/M Investments's Charles River Laboratories position peaked at $2.6M in Q3 2021.
  • 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on F/M Investments's 13F filing for Q1 2026, filed 11 May 2026.